[Basic therapy in children with leukemia and a malignant tumors. II].
D000493:Allopurinol / Q000627:therapeutic use; D000707:Anaphylaxis / Q000517:prevention & control; D000740:Anemia / Q000628:therapy; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D001639:Bicarbonates / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003556:Cystitis / Q000139:chemically induced; D004211:Disseminated Intravascular Coagulation / Q000628:therapy; D004912:Erythrocytes; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006323:Heart Arrest / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000528:radiation effects; D007938:Leukemia / Q000628:therapy*; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D009154:Mutation / Q000187:drug effects; D009369:Neoplasms / Q000628:therapy*; D010743:Phospholipids / Q000627:therapeutic use; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000628:therapy; D014527:Uric Acid / Q000037:antagonists & inhibitors
D000903:Antibiotics, Antineoplastic; D001639:Bicarbonates; D010743:Phospholipids; D014527:Uric Acid; D000493:Allopurinol; D005665:Furosemide; D006493:Heparin; D015122:Mercaptopurine
Basis therapie bei Kindern mit Leukämien und malignen Tumoren, Teil II.